Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.
Improvements in corticosteroids (improved pharmacokinetics) and β 2-adrenoceptor agonists (longer ... Weiss, K. B. & Sullivan, S. D. The health economics of asthma and rhinitis.
Our results support that the use of β2-agonists should be controlled and restricted to athletes with documented asthma. Systematic review registration PROSPERO CRD42018109223.
Medpage Today on MSN3mon
What Is the Optimal Reliever Therapy for Difficult-to-Control Asthma?BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for ...
Patients: Children 2–18 years old with a primary diagnosis code for asthma supported with mechanical ... less likely to receive inhaled b-agonists, ipratropium bromide, and heliox, but more ...
COPD: Chronic obstructive pulmonary disease; EIB: Exercise-induced bronchoconstriction; IβA: Inhaled β 2-agonist; ICS: Inhaled corticosteroid. Globally, the prevalence of asthma continues to ...
regimens (using SABA [short-acting beta2 agonist] as a reliever) compared with 'as-needed' strategies (for example ICS/formoterol) as the initial standard treatment for asthma in children aged 5 to 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback